RxDoctor Payments DataLook up a doctor →

Kindra Hunt, APRN

Family · Provo, UTNPI 1902436611

Payments from drug & device makers

$118,332in general payments, 2019–2025

Across 1,219 payments — averaging $97.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$88K
  • Biohaven Pharmaceuticals, Inc.$16K
  • Biohaven Pharmaceutical Holding Company Ltd.$4K
  • Medtronic$1K
  • EMD Serono, Inc.$746
  • Teva Pharmaceuticals USA, Inc.$622
  • plus $8K from 45 others
$280in research payments, 2019–2025

Across 1 payment — averaging $280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$280

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)337$88,335
Biohaven Pharmaceuticals, Inc.63$15,735
Biohaven Pharmaceutical Holding Company Ltd.59$4,195
Medtronic57$1,113
EMD Serono, Inc.72$746
Teva Pharmaceuticals USA, Inc.90$622
Neurocrine Biosciences, Inc.48$586
SK Life Science, Inc.35$578
Acadia Pharmaceuticals Inc48$529
Biogen30$522
UCB, Inc.27$457
MDD US Operations, LLC30$369
Amneal Pharmaceuticals LLC25$337
AstraZeneca13$279
Sanofi15$277
Johnson & Johnson21$268
Supernus Pharmaceuticals, Inc.24$257
Lilly USA, LLC16$241
Adamas Pharmaceuticals, Inc.22$222
Bristol Myers Squibb22$209
TG Therapeutics, Inc.8$192
Genentech USA, Inc.14$179
Impel Pharmaceuticals Inc.18$174
Amgen17$167
Novartis13$166
Avanir Pharmaceuticals, Inc.8$137
Tanabe Pharma America, Inc.9$135
Upsher-smith Laboratories LLC8$128
Jazz Pharmaceuticals Inc.6$120
Sunovion Pharmaceuticals Inc.9$118
Livanova USA, Inc.6$117
Kyowa Kirin, Inc.5$97
Lundbeck LLC6$93
Neurelis, Inc.6$85
Pfizer4$67
Banner Life Sciences, LLC4$60
ANI Pharmaceuticals, Inc.3$54
Eisai Inc.2$50
Avion Pharmaceuticals2$33
Boston Scientific2$33
Almatica Pharma LLC2$31
Exeltis, USA Inc.1$29
Mallinckrodt Hospital Products Inc.2$29
E.r. Squibb & Sons, L.L.C.2$24
Sumitomo Pharma America, Inc.2$22
Argenx US, Inc.1$20
Zogenix Inc.1$20
CSL Behring1$20
Grifols USA, LLC1$19
Catalyst Pharmaceuticals, Inc.1$18
Alnylam Pharmaceuticals Inc.1$17

How this compares

$118,332 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah →

Medicare billing

Part B allowed, 2024
$3,335
Medicare patients
51
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Provo

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →